Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peripheral Nervous System Diseases × Glutamine × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Genitourinary 1

Conditions

Multiple Myeloma 2 Recurrence 1 Peripheral Nervous System Diseases 1 Neoplasms, Plasma Cell 1

Interventions

Acupuncture Therapy 3 Dexamethasone 2 Bortezomib 2 Tablets 1 Lenalidomide 1 Glutamine 1 G(M1) Ganglioside 1 Fenofibrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01783522 2019-10-22

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Case Comprehensive Cancer Center

Phase 2 Terminated

9 enrolled 10 charts

Multiple Myeloma, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡